This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Baxter International Inc., Quadra Logic Technologies, Inc.. Active years: 1994-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2,533 
1 out of 13 Years Active: 1994-1997
Title: Herma C Neyndorff: Innovator in Pathogen Inactivation Methods
Introduction
Herma C Neyndorff is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of pathogen inactivation, particularly in medical applications. With a total of 2 patents, Neyndorff's work focuses on improving safety and efficacy in blood component treatments.
Latest Patents
Neyndorff's latest patents include innovative methods for inactivating pathogens in various body fluids. The first patent describes a method for inactivating pathogens in compositions containing cells. This invention minimizes adverse effects caused by photosensitive agents while retaining their disinfecting activity. The process involves reducing extracellular fluid, such as plasma proteins, before irradiating the body fluid with a photoactive drug. After irradiation, the resultant body fluid is protected from contacting additional extracellular fluid for a predefined period.
The second patent also addresses pathogen inactivation in erythrocytes using photoactive methods. Similar to the first, this invention aims to enhance the safety of blood components by minimizing the negative effects of photosensitive agents while ensuring effective disinfection.
Career Highlights
Throughout his career, Neyndorff has worked with prominent companies in the medical technology sector. He has been associated with Baxter International Inc. and Quadra Logic Technologies, Inc., where he contributed to advancements in medical treatments and technologies.
Collaborations
Neyndorff has collaborated with notable professionals in his field, including John R Chapman and Patricia M Logan. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pathogen inactivation.
Conclusion
Herma C Neyndorff's contributions to the field of pathogen inactivation are significant and impactful. His innovative methods enhance the safety of blood components, showcasing his dedication to improving medical technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile